Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-Cyclopentenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane is a dioxaborolane chemical compound characterized by its stability and reactivity in organic transformations. It features a cyclopentenyl group and four tetramethyl groups, which contribute to its unique properties and enable it to participate in a variety of reactions, such as cross-coupling reactions. This versatile compound serves as a key intermediate in the synthesis of complex organic molecules and has been utilized in the development of new pharmaceuticals and agrochemicals.

287944-10-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 287944-10-9 Structure
  • Basic information

    1. Product Name: 2-CYCLOPENTENYL-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE
    2. Synonyms: 2-CYCLOPENTENYL-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE;1-Cyclopentenyl boronic acid pinacol ester;2-(Cyclopent-2-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;Cyclopenten-1-ylboronic acid, pinacol ester;1,3,2-Dioxaborolane, 2-(1-cyclopenten-1-yl)-4,4,5,5-tetraMethyl-;2-(1-Cyclopenten-1-yl)-4,4,5,5-tetraMethyl-1,3,2-dioxaborolane;2-(cyclopent-1-en-1-yl)-4,4,5,5-tetraMethyl-1,3,2- dioxaborolane;1-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1-cyclopentene
    3. CAS NO:287944-10-9
    4. Molecular Formula: C11H19BO2
    5. Molecular Weight: 194.07836
    6. EINECS: 1308068-626-2
    7. Product Categories: Organoborons
    8. Mol File: 287944-10-9.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 210 °C at 760 mmHg
    3. Flash Point: 80.8 °C
    4. Appearance: /
    5. Density: 0.96 g/cm3
    6. Vapor Pressure: 0.284mmHg at 25°C
    7. Refractive Index: 1.463
    8. Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
    9. Solubility: N/A
    10. CAS DataBase Reference: 2-CYCLOPENTENYL-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 2-CYCLOPENTENYL-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE(287944-10-9)
    12. EPA Substance Registry System: 2-CYCLOPENTENYL-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE(287944-10-9)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 26-37
    4. WGK Germany:
    5. RTECS:
    6. TSCA: No
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 287944-10-9(Hazardous Substances Data)

287944-10-9 Usage

Uses

Used in Organic Synthesis:
2-Cyclopentenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane is used as a reagent and building block in organic synthesis for its ability to participate in various reactions, including cross-coupling reactions, and its stability and reactivity in organic transformations.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 2-cyclopentenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane is used as a key intermediate in the synthesis of complex organic molecules, contributing to the development of new pharmaceuticals.
Used in Agrochemical Development:
Similarly, in the agrochemical industry, this compound is utilized as a key intermediate for the synthesis of complex organic molecules, aiding in the development of new agrochemicals.

Check Digit Verification of cas no

The CAS Registry Mumber 287944-10-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,7,9,4 and 4 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 287944-10:
(8*2)+(7*8)+(6*7)+(5*9)+(4*4)+(3*4)+(2*1)+(1*0)=189
189 % 10 = 9
So 287944-10-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H19BO2/c1-10(2)11(3,4)14-12(13-10)9-7-5-6-8-9/h7H,5-6,8H2,1-4H3

287944-10-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name Cyclopenten-1-ylboronic acid, pinacol ester

1.2 Other means of identification

Product number -
Other names 2-(1-Cyclopenten-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:287944-10-9 SDS

287944-10-9Downstream Products

287944-10-9Relevant articles and documents

Development and Mechanistic Studies of Iron-Catalyzed Construction of Csp2-B Bonds via C-O Bond Activation

Geng, Shasha,Zhang, Juan,Chen, Shuo,Liu, Zhengli,Zeng, Xiaoqin,He, Yun,Feng, Zhang

supporting information, p. 5582 - 5588 (2020/07/08)

Herein we describe an iron-catalyzed borylation of alkenyl and aryl carbamates through the activation of a C-O bond. This protocol exhibits high efficiency, a broad substrate scope, and the late-stage borylation of biorelevant compounds, thus providing potential applications in medicinal chemistry. Moreover, this method enables orthogonal transformations of phenol derivatives and also offers good opportunities for the synthesis of multisubstituted arenes. Preliminary mechanistic studies suggest that a FeII/FeIII catalytic cycle via a radical pathway might be involved in the reaction.

Rhodium-Catalyzed Deoxygenation and Borylation of Ketones: A Combined Experimental and Theoretical Investigation

Tao, Lei,Guo, Xueying,Li, Jie,Li, Ruoling,Lin, Zhenyang,Zhao, Wanxiang

supporting information, p. 18118 - 18127 (2020/11/26)

The rhodium-catalyzed deoxygenation and borylation of ketones with B2pin2 have been developed, leading to efficient formation of alkenes, vinylboronates, and vinyldiboronates. These reactions feature mild reaction conditions, a broad substrate scope, and excellent functional-group compatibility. Mechanistic studies support that the ketones initially undergo a Rh-catalyzed deoxygenation to give alkenes via boron enolate intermediates, and the subsequent Rh-catalyzed dehydrogenative borylation of alkenes leads to the formation of vinylboronates and diboration products, which is also supported by density functional theory calculations.

Copper-catalyzed cross-coupling of vinyliodonium salts and diboron reagents to generate alkenyl boronic esters

Bao, Robert Li-Yuan,Gan, Shaoyan,Shi, Lei,Zhu, Dan

supporting information, p. 5567 - 5570 (2020/08/21)

An efficient approach for the synthesis of alkenyl boronic esters through the copper-catalyzed cross-coupling of vinyliodonium salts and diboron reagents is reported. This method is distinguished by its mild conditions and short reaction time of less than

Catalytic enantioselective allylboration of propargylic aldehydes

Bhakta, Urmibhusan,Sullivan, Erin,Hall, Dennis G.

, p. 678 - 683 (2014/02/14)

Homoallylic propargylic alcohols are important building blocks in natural product synthesis. This moiety can be transformed into various other structures by performing other known transformations, which can in turn lead to the synthesis of biologically us

Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation

-

Paragraph 1781; 1782; 1783, (2013/03/26)

The present invention relates to compounds defined by formula I wherein the variables R1-R8 are defined as in the description, possessing valuable pharmacological activity. Particularly, the compounds are inhibitors of cholesterol ester transfer protein (CETP) and thus are suitable for treatment and prevention of diseases which can be influenced by inhibition of this enzyme.

5-SUBSTITUTED 2-PHENYLQUINOLINE COMPLEXES MATERIALS FOR LIGHT EMITTING DIODE

-

Page/Page column 62-63, (2012/11/13)

Compounds are provided that comprise a ligand having a 5-substituted 2-phenylquinoline. In particular, the 2-phenylquinoline may be substituted with a bulky alkyl at the 5-position. These compounds may be used in organic light emitting devices, in particular as red emitters in the emissive layer of such devices, to provide devices having improved properties.

TRICYCLIC PYRIDINE DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PREPARATION

-

Page/Page column 123, (2012/03/10)

The present invention relates to compounds defined by formula I wherein the variables R1-R8 are defined as in the description, possessing valuable pharmacological activity. Particularly, the compounds are inhibitors of cholesterol ester transfer protein (CETP) and thus are suitable for treatment and prevention of diseases which can be influenced by inhibition of this enzyme.

TRICYCLIC PYRIDINE DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PREPARATION

-

Page/Page column 230-231, (2012/09/10)

The present invention relates to compounds defined by formula (I), wherein the variables R1-R8 are defined as in the description, possessing valuable pharmacological activity. Particularly, the compounds are inhibitors of cholesterol

Carbon-boron bond cross-coupling reaction catalyzed by -PPh2 containing palladium-indolylphosphine complexes

Chow, Wing Kin,Yuen, On Ying,So, Chau Ming,Wong, Wing Tak,Kwong, Fuk Yee

experimental part, p. 3543 - 3548 (2012/06/15)

This study describes the application of indolylphosphine ligands with a diphenylphosphino moiety to the palladium-catalyzed borylation of aryl chlorides. The combination of palladium metal precursor with PPh 2-Andole-phos, which comprises an inexpensive -PPh2 group, provides highly effective catalysts for the borylation of aryl chlorides. A range of functional groups such as -CN, -NO2, -CHO, -COMe, -COOMe, and -CF3 was compatible, and the catalyst loading down to 0.025 mol % of Pd can be achieved. The Pd/PPh2-Andole-phos system is able to catalyze both borylation reaction and Suzuki-Miyaura coupling reaction in a one-pot sequential manner for the direct synthesis of biaryl compounds in excellent yields.

TRICYCLIC PYRIDINE DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PREPARATION

-

Page/Page column 230-231, (2011/09/19)

The present invention relates to compounds defined by formula (I) wherein the variables R1-R8 are defined as in the description, possessing valuable pharmacological activity. Particularly, the compounds are inhibitors of cholesterol

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 287944-10-9